Edd Fleming currently serves as Executive Vice President of Commercialization at Enavate Sciences and as a Board Member for egnite Health, Komodo Health, CRISPR Therapeutics, and Vanderbilt School of Basic Sciences. In addition, Edd holds the position of Senior Advisor and formerly served as Senior Partner at McKinsey & Company since 1997. Edd's early career includes a fellowship in Pulmonary and Critical Care at the University of California, San Francisco, and a residency in Internal Medicine at Johns Hopkins Hospital. Edd earned a Doctor of Medicine degree from Vanderbilt University School of Medicine and a Bachelor of Arts in Chemistry from Harvard University, with prior education at Phillips Exeter Academy and Spartanburg Day School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices